These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24739833)

  • 61. Comprehensive expression analysis of pathogenicity genes in uropathogenic Escherichia coli strains.
    Paniagua-Contreras GL; Hernández-Jaimes T; Monroy-Pérez E; Vaca-Paniagua F; Díaz-Velásquez C; Uribe-García A; Vaca S
    Microb Pathog; 2017 Feb; 103():1-7. PubMed ID: 27993701
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence and characterization of uropathogenic Escherichia coli harboring plasmid-mediated quinolone resistance in a Tunisian university hospital.
    Sana F; Mabrouka S; Claudine Q; Faouzi SA; Ilhem BB; Véronique D
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):247-51. PubMed ID: 24731835
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice.
    Vellinga A; Murphy AW; Hanahoe B; Bennett K; Cormican M
    J Antimicrob Chemother; 2010 Jul; 65(7):1514-20. PubMed ID: 20457673
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli.
    Lüthje P; Brauner A
    J Clin Microbiol; 2010 Feb; 48(2):675-6. PubMed ID: 19955281
    [No Abstract]   [Full Text] [Related]  

  • 65. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 66. O-serogroups of multi-drug resistant cervicovaginal Escherichia coli harboring a battery of virulence genes.
    Paniagua-Contreras GL; Monroy-Pérez E; Solis RR; Cerón AB; García Cortés LR; Alonso NN; Camarillo DH; Arreygue LS; Domínguez-Trejo P; Velásquez CD; Vaca-Paniagua F; Uribe-García A; Vaca S
    J Infect Chemother; 2019 Jul; 25(7):494-497. PubMed ID: 30824302
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Microbial susceptibility, virulence factors, and plasmid profiles of uropathogenic Escherichia coli strains isolated from children in Jahrom, Iran.
    Farshad S; Ranjbar R; Japoni A; Hosseini M; Anvarinejad M; Mohammadzadegan R
    Arch Iran Med; 2012 May; 15(5):312-6. PubMed ID: 22519382
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of Escherichia coli urinary tract infection isolates in remote northern Saskatchewan communities: the Northern Antibiotic Resistance Partnership.
    Golding GR; Persaud N; Levett PN; McDonald RR; Irvine J; Nsungu M; Woods S; Khan M; Mataseje LF; Mulvey MR;
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):242-7. PubMed ID: 22944458
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Some virulence characteristics of uropathogenic Escherichia coli in different patient groups.
    Naveen R; Mathai E
    Indian J Med Res; 2005 Aug; 122(2):143-7. PubMed ID: 16177472
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antimicrobial activity data in support of nitrofurantoin three times per day.
    Amábile-Cuevas CF; Arredondo-García JL
    J Antimicrob Chemother; 2011 Jul; 66(7):1652-3. PubMed ID: 21525023
    [No Abstract]   [Full Text] [Related]  

  • 71. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
    Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Virulence factor profiles, phylogenetic background, and antimicrobial resistance pattern of lactose fermenting and nonlactose fermenting Escherichia coli from extraintestinal sources.
    Chakraborty A; Adhikari P; Shenoy S; Saralaya V
    Indian J Pathol Microbiol; 2016; 59(2):180-4. PubMed ID: 27166036
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recurrent urinary tract infections caused by multidrug-resistant uropathogenic Escherichia coli: implications for diagnosis and treatment.
    Liu S; Zhang N; Chen Z
    Eur Urol; 2013 Feb; 63(2):410-1. PubMed ID: 23177082
    [No Abstract]   [Full Text] [Related]  

  • 75. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
    Yeshitela B; Gebre-Selassie S; Feleke Y
    Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Virulence characteristics and antimicrobial susceptibility of uropathogenic Escherichia coli strains.
    Oliveira FA; Paludo KS; Arend LN; Farah SM; Pedrosa FO; Souza EM; Surek M; Picheth G; Fadel-Picheth CM
    Genet Mol Res; 2011 Oct; 10(4):4114-25. PubMed ID: 22057993
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Distribution of phylogenetic groups and virulence factors in CTX-M-15 β-lactamase-producing uropathogenic Escherichia coli strains isolated from patients in the community of Mérida, Venezuela].
    Millán Y; Hernández E; Millán B; Araque M
    Rev Argent Microbiol; 2014; 46(3):175-81. PubMed ID: 25444124
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections.
    Gulsun S; Oguzoglu N; Inan A; Ceran N
    Saudi Med J; 2005 Nov; 26(11):1755-8. PubMed ID: 16311661
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Resistance and virulence potential of uropathogenic Escherichia coli strains isolated from patients hospitalized in urology departments: a French prospective multicentre study.
    Lavigne JP; Bruyère F; Bernard L; Combescure C; Ronco E; Lanotte P; Coloby P; Thibault M; Cariou G; Desplaces N; Costa P; Sotto A
    J Med Microbiol; 2016 Jun; 65(6):530-537. PubMed ID: 26953145
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Investigation of antibiotic resistance determinants and virulence factors of uropathogenic Escherichia coli.
    Sun DH; Lv DF; Mi ZH; Hu LQ; Huang Y; Gao X; Weng XB
    J Antibiot (Tokyo); 2020 May; 73(5):314-319. PubMed ID: 32076117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.